Experimental anti-cholesterol drug shows promise
People taking an experimental drug called Repatha (evolocumab) for high cholesterol were half as likely to die or suffer a heart attack or stroke as those taking conventional statins, researchers said Sunday.
Mar 15, 2015
4
131